An approach to estimating prognosis using fractional polynomials in metastatic renal carcinoma

British Journal of Cancer

Volumn 94, Issue 12, 2006, Pages 1785-1788

  Royston, P ^a   Reitz, M ^b   Atzpodien, J ^b,c,d  

^a MRC CLINICAL TRIALS UNIT   (United Kingdom)

^b Europaisches Institut fur Tumor Immunologie und Pravention   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Fractional polynomials; Immunotherapy; Prognosis; Renal cell carcinoma; Risk

Indexed keywords

C REACTIVE PROTEIN; FLUOROURACIL; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT INTERLEUKIN 2;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER RISK; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; UNSPECIFIED SIDE EFFECT;

ALGORITHMS; CLINICAL TRIALS; FEMALE; HUMANS; IMMUNOTHERAPY; KIDNEY NEOPLASMS; MALE; MODELS, STATISTICAL; NEOPLASM METASTASIS; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 33745092900     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603192     Document Type: Article

References (18)

1. Atzpodien J, Royston P, Reitz M (2003) Metastatic renal carcinoma extended staging system. Br J Cancer 88(3): 348-353
2. Atzpodien J, Kirchner H, Jonas U, Bergmann L, Schott H, Heynemann H, Fornara P, Loening SA, Roigas J, Muller SC, Bodenstein H, Pomer S, Metzner B, Rebmann U, Oberneder R, Siebels M, Wandert T, Puchberger T, Reitz M (2004) Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). J Clin Oncol 22(7): 1188-1194
3. Culine S, Bekradda M, Kramar A, Rey A, Escudier B, Droz JP (1998) Prognostic factors for survival in patients with brain metastases from renal cell carcinoma. Cancer 83(12): 2548-2553
4. Elson PJ, Witte RS, Trump DL (1988) Prognostic factors for survival in patients with recurrent or metastatic renal cell carcinoma. Cancer Res 48(24 Part 1): 7310-7313
5. Gelb AB (1997) Renal cell carcinoma: current prognostic factors. Union Internationale Contre le Cancer (UIC) and American Joint Committee on Cancer (AJCC). Cancer 80(5): 981-986
6. Harrell Jr FE (2001) Regression Modelling Strategies. New York: Springer, p 493
7. Hoffmann R, Franzke A, Buer J, Sel S, Oevermann K, Duensing A, Probst M, Duensing S, Kirchner H, Ganser A, Atzpodien J (1999) Prognostic impact of in vivo soluble cell adhesion molecules in metastatic renal cell carcinoma. Br J Cancer 79(11-12): 1742-1745
8. Lopez-Hänninen E, Kirchner H, Atzpodien J (1996) Interleukin-2-based home therapy of metastatic renal cell carcinoma: risks and benefits in 215 consecutive single institution patients. J Urol 155: 19-25
9. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM, for the Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics (2005) REporting recommendations for tumour MARKer prognostic studies (REMARK). Nat Clin Pract Oncol 2(8): 416-422
10. Motzer RJ, Bacik J, Murphy BA, Russo P, Mazumdar M (2002) Interferon-alpha as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma. J Clin Oncol 20(1): 289-296
11. Motzer RJ, Mazumdar M, Bacik J, Berg W, Amsterdam A, Ferrara J (1999) Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol 17(8): 2530-2540
12. Palmer PA, Vinke J, Philip T, Negrier S, Atzpodien J, Kirchner H, Oskam R, Francs CR (1992) Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombined interleukin-2. Annu Oncol 3(6): 475-480
13. Royston P, Altman DG (1994) Regression using fractional polynomials of continuous covariates: parsimonious parametric modelling (with Discussion). Appl Stat 43: 429-467
14. Royston P, Sauerbrei W (2004) A new measure of prognostic separation in survival data. Stat Med 23: 723-748
15. Sauerbrei W, Meier-Hirmer C, Benner A, Royston P (2006) Multivariable regression models by using fractional polynomials: description of SAS, Stata and R programs. Comput Stat Data Anal (in press)
16. Sauerbrei W, Royston P (1999) Building multivariable prognostic and diagnostic models: transformation of the predictors by using fractional polynomials. J R Stat Soc (Ser A) 162: 71-94
17. Sauerbrei W, Royston P, Bojar H, Schmoor C, Schumacher M, the German Breast Cancer Study Group (1999) Modelling the effects of standard prognostic factors in node positive breast cancer. Br J Cancer 79: 1752-1760
18. Simon R, Altman DG (1994) Statistical aspects of prognostic factor studies in oncology. Br J Cancer 69: 979-985